In addition, using genome-wide analysis of DNA methylation, Yamada et al. reported that the MAP4K4 promoter is hypermethylated in Japanese patients with atherosclerosis, which is one of the fatal complications associated with T2D [33]. Here, MAP4K4 is linked to type 2 diabetes mellitus.